Menú
Meet the Program Commitee for 2021!
Comité del programa
-
Magda Chlebus, MA • Executive Director, Science Policy & Regulatory Affairs
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium -
Inaki Gutierrez-Ibarluzea • Director of organizational innovation and management
BIOEF, Spain -
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Esa Henrik Heinonen, DrMed • Director, Assessment of Medicinal Products
Finnish Medicines Agency (Fimea), Finland -
Claire Hill-Venning, PhD • Senior Director Regulatory Policy
Janssen, United Kingdom -
Hubert Leufkens, PharmD, PhD • Emeritus Professor of Pharmaceutical Policy and Regulatory Science
Utrecht University, Netherlands -
Alexander Natz, JD • Secretary General
European Confederation of Pharmaceutical Entrepreneurs, Belgium -
Lorraine Nolan, PhD • Chief Executive
Health Products Regulatory Authority , Ireland -
Susanne Ausborn, PhD • Global Head International Regulatory Policy
Roche, Switzerland -
Andrew Bate, PhD, MA • Vice President, Head of Safety Innovation and Analytics
GlaxoSmithKline, United Kingdom -
Simon Bennett, MSc • Director, EU Regulatory Policy
Biogen, United Kingdom -
Susan Bhatti, PhD • Director EU Global Regulatory and Scientific Policy, Global Regulatory Affairs
Merck BV, Netherlands -
Patrick Brady, PharmD • Global Head, Therapeutic Innovation & Regulatory Science
IQVIA, United States -
Gabriele Braeunlich, PhD • Head Regulatory Affairs Strategy
Bayer AG, Germany -
Mireille Collombat, PharmD • Senior Director Group Leader, Global Drug Regulatory Affairs
Actelion Pharmaceuticals Ltd., Switzerland -
Emma Du Four, MBA • Independent Regulatory and R&D Policy Professional
Independent, United Kingdom -
Benjamin Horbach, MSc • Health Systems Strategy Leader - Personalised Healthcare
F. Hoffmann-La Roche, Switzerland -
Jürgen Kübler, PhD • Owner
Quantitative Scientific Consulting, Germany -
Frank Montgomery, PhD • Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom -
Paolo Morgese, MSc • Head of Public Affairs
Alliance for Regenerative Medicine (ARM), Belgium -
Mireille Muller, DrSc, PhD, MSc • Regulatory Policy & Intelligence Director
Novartis Pharma AG, Switzerland -
Dolores Hernan Perez de la Ossa, PhD • Quality Specialist - Pharmaceutical Quality Office
European Medicines Agency, Netherlands -
Gavin Outteridge, MA • Managing Director
AESARA Europe, United Kingdom -
Florence Roizard, PharmD • Vice President, Regulatory Affairs International
MSD France, France -
Oliver Sude, PhD • Legal Counsel, EU Affairs
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium -
Hans van Bruggen, MSc • CSO
Qdossier, a Celegence Company, Netherlands -
Willemijn van der Spuij, MSc • Executive Director, WorldWide Patient Safety International, Europe
Switzerland -
Andrew Thomson, PhD, MA, MS • Statistician, Methodology Taskforce
European Medicines Agency, Netherlands